Team finds key to gene-silencing activity, opens door to new class of therapies
Thursday, May 9, 2013 - 11:00
in Health & Medicine
A team led by scientists at The Scripps Research Institute (TSRI) has found how to boost or inhibit a gene-silencing mechanism that normally serves as a major controller of cells' activities. The discovery could lead to a powerful new class of drugs against viral infections, cancers and other diseases.